Home › Cardiovascular Disease › Florida › Deltona
Cardiovascular Disease clinical trials in Deltona, FL
4 studies for Cardiovascular Disease are looking for participants at sites in and around Deltona (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Hillcrest Medical Research, DeLand · 9 mi away
- University Clinical Research Deland, LLC, DeLand · 9 mi away
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Arrow Clinical Trails, Daytona Beach · 26 mi away
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Progressive Medical Research, Port Orange · 23 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, DeLand · 9 mi away
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- San Francisco, CA18 studies
Other studies in Deltona
- Non-Small Cell Lung Cancer15 studies
- Obesity11 studies
- Type 2 Diabetes10 studies
- Alzheimer's Disease10 studies
- Overweight9 studies
- Breast Cancer8 studies
- Lung Cancer8 studies
- Cancer (all types)7 studies
- High Blood Pressure5 studies
- Knee Osteoarthritis5 studies
- Metastatic Cancer5 studies
- Melanoma5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.